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Extra virgin olive oil use is associated with improved
post-prandial blood glucose and LDL cholesterol in
healthy subjects
F Violi1, L Loffredo1, P Pignatelli1, F Angelico2, S Bartimoccia1, C Nocella1, R Cangemi1, A Petruccioli3, R Monticolo4, D Pastori1
and R Carnevale1,4
OBJECTIVES: Extra virgin olive oil (EVOO) is a key component of the Mediterranean diet and seems to account for the protective
effect against cardiovascular disease. However, the underlying mechanism is still elusive.
DESIGN: We tested the effect of EVOO, added to Mediterranean-type meal, on post-prandial glycemic and lipid profile.
SUBJECTS: Post-prandial glycemic and lipid profile were investigated in 25 healthy subjects who were randomly allocated in a
cross-over design to a Mediterranean-type meal added with or without 10 g EVOO (first study), or Mediterranean-type meal with
EVOO (10 g) or corn oil (10 g; second study). Glycemic profile, which included glucose, insulin, dipeptidyl-peptidase-4 (DPP-4)
protein and activity, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), and lipid profile,
which included, low-density lipoprotein (LDL) cholesterol (LDL-C), oxidized LDL (ox-LDL), triglycerides and high-density lipoprotein
(HDL) cholesterol (HDL-C), were analyzed before and 2 h after the meal.
RESULTS: In the first study, 2 h after meal, subjects who assumed a meal with EVOO had significantly lower blood glucose
(Po0.001), DPP-4 protein (Po0.001) and activity (Po0.001), LDL-C (Po0.001) and ox-LDL (Po0.001) and higher insulin (Po0.05),
GLP-1 (Po0.001) and GIP (Po0.05) compared with those without EVOO. The second study showed that compared with corn oil,
EVOO improved both glycemic and lipid profile. Thus, a significantly smaller increase of glucose (Po0.05), DPP4 protein (Po0.001)
and activity (Po0.05) and higher increase of insulin (Po0.001) and GLP-1 (Po0.001) were observed. Furthermore, compared with
corn oil, EVOO showed a significantly less increase of LDL-C (Po0.05) and ox-LDL (Po0.001).
CONCLUSIONS: We report for the first time that EVOO improves post-prandial glucose and LDL-C, an effect that may account for
the antiatherosclerotic effect of the Mediterranean diet.
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INTRODUCTION
Mediterranean diet is the golden standard for healthy nutrition
and is associated with reduced risk of cardiovascular events.1
Traditionally, Mediterranean diet is characterized by high intake of
fruits, vegetables, cereals, fish and moderate wine consumption,
with scarce intake of dairy products and red meat. Most important,
the health benefits of Mediterranean diet have been attributed to
the high intake of monounsaturated fat, mostly represented by
extra virgin olive oil (EVOO). Thus, recent results from the
PREDIMED study showed that EVOO added to the Mediterranean
diet reduces the risk of cardiovascular events compared with
controls.1 Among the mechanism(s) potentially attributable to the
antiatherosclerotic effect, the prevention of new-onset diabetes
might have a role, but the biologic plausibility of such positive
association is still unclear. Prevention of diabetes might be
attributable to the antioxidant property of EVOO;2 thus, oxidative
stress seems to be implicated in β-cells dysfunction and eventually
diabetes.3 Furthermore, oxidative stress is responsible for activation
of dipeptidyl-peptidase-4 (DPP-4),4 which cleaves incretins down-
regulating insulin secretion.5 We have recently demonstrated that
a Mediterranean-type meal supplemented with EVOO is asso-
ciated with reduced post-prandial oxidative stress generated by
NOX2, the catalytic subunit of NADPH oxidase.6 On the basis of
this finding, we speculated that EVOO, added to Mediterranean-
type meal, could improve post-prandial glycaemic control via an
oxidative stress-mediated mechanism. In addition, we investigated
if EVOO had any effect on lipid profile including analysis of
low-density lipoprotein (LDL)-cholesterol (LDL-C), triglycerides and
high-density lipoprotein (HDL)-cholesterol (HDL-C).
SUBJECTS AND METHODS
Twenty-five healthy subjects (HS; 12 males and 13 females) gave informed
consent to participate in the interventional study, which was performed
between January 2013 and March 2013. Study methodology, clinical and
demographics characteristics of HS and Mediterranean-type lunch have
been previously reported.6 Briefly, a first study consisted in randomizing 25
HS were to receive a typical Mediterranean lunch including or not 10 g of
EVOO (Lago dei Papi, Viterbo, Italy; see Table 1, Supplementary Data) in a
cross-over design; there was an interval of 30 days between the two
phases of the study. Mediterranean-type lunch consisted of pasta (100 g),
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chicken breast (150 g), salad (80 g), bread (80 g), apple (200 g) for a total of
894 calories. After 1 month from the end of the first study the same
subjects (n= 25) participated to a second study in which they were
randomly allocated to receive a lunch with EVOO (10 g) or corn oil (10 g) in
a cross-over design. There was an interval of 30 days between the two
phases of the study. For each phase of the study, a blood sample was taken
before (at 1300 hours) and 2 h after the lunch. Every blood determination
was performed blind. None of the participants were receiving antioxidants
supplements or statin. The study was conformed to the ethical guidelines
of the 1975 Declaration of Helsinki and was approved by the Ethical
Committee of Sapienza University.
Laboratory analysis
Blood concentration of glucose, insulin, total GLP1 (7–36 and 9–36
peptides), total GIP, DPP-4 protein and activity, ox-LDL, LDL-C, triglycerides
and HDL-C were measured by ELISA Kit (Sigma Aldrich, DRG International,
Cusabio, Boster). Oil analysis were described in Supplementary Data.
Sample size
As regards the interventional cross-over study, we computed the minimum
sample size with respect to a two-tailed one-sample Student’s t-test,
considering as (i) glucose variation to be detected between extra virgin oil
and corn oil treatment |δ|≥ 15mg dl− 1, (ii) s.d. of the paired differences
s.d. = 15mg dl− 1, (iii) type I error probability α= 0.05 and power
1− β= 0.90. This resulted in a minimum sample size of 10 per group.
Statistical methods
Categorical variables are reported as counts (percentage) and continuous
variables as means± s.d. unless otherwise indicated. Independence of
categorical variables was tested by χ2-test. Comparisons between groups
were carried out by Student’s t-test and were replicated as appropriate
with nonparametric tests (Kolmogorov–Smirnov (z) test in case of
nonhomogeneous variances as verified by Levene’s test).
The cross-over study data were analyzed for the assessment of
treatment and period effects, by performing a split-plot ANOVA with one
between-subject factor (treatment sequence) and two within-subject
factors (period 1 vs 2; pre- vs post-treatment). The analysis was performed
separately to compare a meal with and without EVOO and a meal with
EVOO vs corn oil. The full model was considered, allowing for the
assessment of all main effects and interactions. Pairwise comparisons were
corrected by the Bonferroni test; results were expressed as means ± s.e.
Bivariate analysis was performed by Spearman rank correlation test.
A value of Po0.05 was considered statistically significant. All analyses
were carried out with SPSS V.18.0 (SPSS Statistics v. 18.0, SPSS Inc., Chicago,
IL, USA).
RESULTS
EVOO vs non-EVOO effect on post-prandial glycaemic control
In the first study, we compared the effect of EVOO added or not to
a Mediterranean-type lunch. At baseline, no differences in blood
variables were detected (Figure 1). Two hours after a
Mediterranean-type lunch, a significant difference for treatments
(meal with vs without EVOO) was found with respect to glucose
(F = 27.8, Po0.001; Figure 1a), insulin (F = 38.3, Po0.001;
Figure 1b), GLP1 (F = 31.0, Po0.001; Figure 1c), GIP (F = 5.3,
P= 0.025; Figure 1d), DPP-4 concentration (F = 62.9, Po0.001;
Figure 1e) and DPP-4 activity (F = 16.0, Po0.001; Figure 1f).
In particular, compared with baseline, when a meal not
containing EVOO was given, glucose concentration and insulin
increased significantly (Figures 1a and b; Table 1). Conversely,
compared with baseline, in subjects given a meal containing
EVOO, a less increase of blood glucose and a more marked
increase of blood insulin were detected (Figures 1a and b; Table 1).
Analysis of incretins’ secretion showed significant differences
between the meal with and without EVOO. Thus, incretins
increased more significantly in subjects supplemented with EVOO
compared with those who did not receive it (Figures 1c and d;
Table 1); furthermore, DPP-4 protein and activity showed a lower
increase after meal with EVOO (Figures 1e and f; Table 1).
EVOO vs non-EVOO effect on post-prandial lipid profile
At baseline, no differences of blood variables were detected
(Figure 2). Two hours after a Mediterranean-type lunch, a
significant difference for treatments (meal with vs without EVOO)
was found with respect to LDL-C (F = 6.4, P= 0.014; Figure 2a) and
ox-LDL (F = 144.0, Po0.001; Figure 2b). No significant difference
was found with respect to triglycerides and HDL-C (Figures 2c and d).
In particular, compared with baseline, when a meal not containing
EVOO was given, LDL-C, ox-LDL and triglycerides increased
significantly, whereas HDL-C did not change (Figures 2a–d;
Table 1). Conversely, compared with baseline, in subjects given
a meal containing EVOO, a significantly less increase of LDL-C and
ox-LDL was detected, whereas triglycerides and HDL-C did not
change (Figures 2a–d; Table 1). Δ of ox-LDL correlated with Δ of
glycaemia (RS: 0.501; Po0.001), Δ of insulin (RS:-0.492; Po0.001),
Δ of DPP-4 activity (RS: 0.467; P= 0.001), Δ of DPP-4 concentration
(RS = 0.508; Po0.001) and Δ of GLP1 (RS: − 0.353; P= 0.012). Δ of
DPP-4 activity correlated with serum glucose (RS: 0.503; P= 0.001).
EVOO and corn oil effect on post-prandial glycaemic and lipid
profile
When we compared the effect of a meal containing EVOO or corn
oil, a significant difference for treatments with respect to glucose
(F = 13.9, P= 0.01; Figure 3a), insulin (F = 14.4, Po0.001; Figure 3b),
GLP1 (F = 55.6, Po0.001; Figure 3c), DPP-4 concentration (F = 23.0,
Po0.001; Figure 3e), DPP-4 activity (F = 12.5, P= 0.001; Figure 3f),
LDL-C (F = 4.1, Po0.05; Figure 4a) and ox-LDL (F = 67.5, Po0.001;
Figure 4b) was detected. No significant difference for treatments
was found with respect to GIP, triglycerides and HDL-C (Figures 3d
and 4c and d).
Table 1. Post-prandial effect of a meal with and without EVOO on
selected variables
Variables Before After 2 h P-value
Meal with EVOO
Glucose (mg dl− 1) 79.7± 9.7 105.9± 12.1 o0.001
Insulin (μIU ml− 1) 13.2± 4.2 40.8± 7.8 o0.001
GIP (pgml− 1) 64.8± 12.0 109.3± 48.0 o0.001
GLP1 (pmol l− 1) 1.4± 0.7 9.2± 1.7 o0.001
DPP-4 concentration
(pgml− 1)
360.8± 36.4 404.9± 39.9 o0.05
DPP-4 activity (μUml− 1) 30.5± 4.9 34.8± 12.2 o0.05
HDL-C (mg dl− 1) 75.5± 14.3 83.0± 18.8 NS
Triglycerides (mg dl− 1) 89.2± 7.1 105.9± 8.2 o0.001
LDL-C (mg dl− 1) 67.9± 15.0 73.0± 18.0 o0.05
Ox-LDL (mUml− 1) 54.4± 18.3 65.4± 24.7 NS
Meal without EVOO
Glucose (mg dl− 1) 77.8± 8.3 131.4± 20.9 o0.001
Insulin (μIU ml− 1) 11.3± 1.4 27.0± 5.0 o0.001
GIP (pgml− 1) 61.2± 30.0 78.8± 24.6 o0.001
GLP1 (pmol l− 1) 1.6± 0.9 6.1± 1.8 o0.001
DPP-4 concentration
(pgml− 1)
357.0± 33.0 608.9± 115.0 o0.001
DPP-4 activity (μUml− 1) 30.0± 5.9 48.6± 8.5 o0.001
HDL-C (mg dl− 1) 76.2± 12.2 80.8± 17.2 NS
Triglycerides (mg dl− 1) 88.0± 5.7 111.0± 8.6 o0.001
LDL-C (mg dl− 1) 68.6± 19.2 90.5± 13.1 o0.001
Ox-LDL (mUml− 1) 53.7± 17.0 128.9± 29.2 o0.001
Abbreviations: DPP-4, Dipeptidyl peptidase-4; EVOO, extra virgin olive oil;
GIP, glucose-dependent insulinotropic polypeptide; GLP1, glucagon-like
peptide-1; LDL, low-density lipoprotein; NS, not significant; Ox-LDL,
oxidized LDL; LDL-C, LDL-cholesterol; HDL-C, HDL-cholesterol.
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In particular, after 2 h from lunch, in subjects given a
meal containing corn oil, glucose concentration, insulin,
GLP1, GIP, DPP-4 concentration and DPP-4 activity increased
significantly (Figure 3a–f; Table 2). These changes were
associated with a significant increase of LDL-C, ox-LDL
and triglycerides, whereas HDL-C did not significantly change
(Figure 4a–d; Table 2).
Compared with corn oil, subjects given a meal containing
EVOO showed a significantly less increase of blood glucose,
DPP-4 concentration and activity and a more marked increase
of blood insulin, GLP1, GIP (Figure 3a–f; Table 2). Concerning
lipid profile, subjects given EVOO showed a significantly
smaller increase of LDL-C and ox-LDL, whereas triglycerides
showed a non-significant trend toward reduction (Figures 4a–d;
Table 2).
DISCUSSION
This is the first study demonstrating that a Mediterranean-type
meal supplemented with EVOO has a beneficial effect on post-
prandial glycemic and lipid profile by decreasing blood glucose,
LDL-C and ox-LDL.
There is a growing body of evidence to suggest that post-
prandial changes of glycemic and lipid profile might have
Figure 1. Interventional study: blood glucose (a), insulin (b), GLP1 (c), GIP (d), DPP-4 concentration (e) and DPP-4 activity (f) before and after
2 h of a meal with (black line) or without (gray line) extra virgin olive oil (EVOO), *Po0.001, **Po0.05.
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deleterious effect on vascular disease by promoting and/or
aggravating the atherosclerotic process.7,8 Moreover, post-
prandial glucose has been associated with an higher incidence
of cardiovascular events in patients with9 and without
diabetes.10 Thus, blunting or minimizing post-prandial glycemic
and lipid profile could have a positive impact in the progression
of atherosclerosis.11 Observational and interventional
studies consistently demonstrated a potentially beneficial
effect of EVOO on the atherosclerotic process,1,12,13 but the
underlying mechanism is still undefined. Data regarding the
impact of EVOO on post-prandial glycemic and lipid profile are
still lacking. The novelty of the present study is in the
demonstration that EVOO improves the post-prandial glycemic
control by lowering and increasing blood glucose and
insulin, respectively. Post-prandial glycemic control is regulated
by incretins, which upregulate insulin secretion and in turn
lowers blood glucose. Incretins such as GLP1 and GIP are
secreted by distal small intestine in response to its stimulation,
bind receptors in the endocrine pancreas so eliciting insulin
secretion and lowering post-prandial blood glucose and are
rapidly inactivated by DPP-4.14,15 Our approach was to
evaluate whether EVOO may stimulate intestinal cells and trigger
endogenous incretin release. Analysis of GLP-1 and GIP
after Mediterranean-type lunch demonstrated that supplemen-
tation with EVOO was associated with an increase of both
incretins coincidentally with a decrease of DPP-4 activity
suggesting that EVOO behaves as a DPP-4 inhibitor.
The antioxidant effect of EVOO6 may account for the improved
post-prandial glycaemia as oxidative stress is implicated in
incretin secretion and metabolism. Oxidative stress affects, in
fact, insulin signaling cascade, leading to insulin resistance3 and
cumulative hyperglycemia and resultant AGE-induced
ROS generation16 might impair the incretins’ effects via elevation
of circulating DPP-4 concentration.4 Of note, we found
that, compared with control, post-prandial ox-LDL increase
was almost blunted by EVOO and paralleled DPP-4
activity changes with a direct correlation between these
two variables, reinforcing the concept that oxidative stress
upregulates DPP-4 activity4 and eventually inhibits insulin
secretion. Among the EVOO components, oleuropein would be
likely to downregulate NOX-2-derived oxidative stress,6 but
further study is necessary to investigate if the polyphenol
component of EVOO also have a role.
An unexpected finding of the study was the improvement of
lipid profile observed after EVOO administration. Thus, post-
prandial serum LDL-C was significantly reduced compared with
control suggesting a lipid-lowering effect of EVOO. This effect
seems to be specific for LDL-C, as neither triglycerides nor HDL-C
were modified compared with control. The positive impact of
EVOO on post-prandial LDL-C is more difficult to interpret. We
have not data that may help to explain if such beneficial effect
depends on a specific EVOO interference with cholesterol
absorption in the gastrointestinal tract or on a direct activity of
EVOO on cholesterol biosynthesis. This issue deserves further
investigation.
To investigate if these changes on serum glucose and
LDL-C were peculiar for EVOO, we compared EVOO versus
corn oil with regard to the changes of post-prandial glycemic
Figure 2. Interventional study: LDL-C (a), ox-LDL concentration (b), triglycerides (c) and HDL-C (d) before and after 2 h of a meal with (black
line) or without (gray line) extra virgin olive oil (EVOO), *Po0.001, **Po0.05.
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and lipid profile. Also this experiment confirmed the beneficial
effect of EVOO as it significantly improved both glycemic and
lipid profile compared with corn oil so suggesting that its
components may favorably influence glucose and cholesterol
metabolism.
The study has limitation and implication. We have not data
specifically addressing insulin secretion because early serum
glucose and insulin increment after lunch are not available.17
The exact mechanism through which EVOO downregulates DPP-4
has not been addressed in the present study and should be
investigated. It is possible that EVOO downregulates NOX2-
derived oxidative stress,6 but it cannot be excluded that post-
prandial LDL-C lowering may also have a role.18 We cannot
exclude that corn oil may have positive effect when compared
with control as this issue was not investigated in the present
study. The study has been performed in healthy subjects and,
therefore, further study is necessary to see whether EVOO has
such beneficial effect in patients with diabetes or dyslipidemia.
Finally it remains to establish whether the changes observed with
EVOO persist chronically.
While our findings provide a potential explanation for the
inverse association between Mediterranean diet and diabetes risk,
as GLP-1 may reduce cellular apoptosis in the pancreatic β-cells
and promote β-cell proliferation,15 the positive effect of EVOO on
insulin and LDL-C opens new avenues to counteract the
potentially deleterious effects on vascular function related to
post-prandial spikes in glucose and lipid.19
In conclusion, EVOO has beneficial effect on post-prandial
glycemic and LDL-C profile so providing a novel insight into the
Figure 3. Interventional study: blood glucose (a), insulin (b), GLP1 (c), GIP (d), DPP-4 concentration (e) and DPP-4 activity (f) before and after
2 h of a meal with extra virgin olive oil (EVOO; black line) or corn oil (gray line), *Po0.001, **Po0.05.
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Figure 4. Interventional study: LDL-C (a), ox-LDL concentration (b), Triglycerides (c) and HDL-C (d) before and after 2 h of a meal with extra
virgin olive oil (EVOO; black line) or corn oil (gray line), *Po0.001, **Po0.05.
Table 2. Post-prandial effect of a meal with EVOO or corn oil on selected variables
Variables Before After 2 h P-value
Meal with EVOO
Glucose (mg dl− 1) 77.0± 7.8 98.2± 9.1 o0.001
Insulin (μIU ml− 1) 14.6± 5.4 47.6± 16.6 o0.001
GIP (pgml− 1) 72.6± 8.9 131.8± 19.9 o0.001
GLP1 (pmol l− 1) 1.5± 0.4 10.6± 1.2 o0.001
DPP-4 concentration (pgml− 1) 359.6± 33.8 401.0± 49.8 o0.001
DPP-4 activity (μUml− 1) 25.5± 4.9 29.2± 8.9 o0.05
HDL-C(mg dl− 1) 75.3± 16.1 79.6± 19.8 NS
Triglycerides (mg dl− 1) 92.5± 8.1 110.1± 10.6 o0.001
LDL-C (mg dl− 1) 68.4± 14.8 76.2± 17.1 o0.001
Ox-LDL (mUml− 1) 55.6± 10.9 62.6± 11.2 NS
Meal with corn oil
Glucose (mg dl− 1) 79.0± 8.5 119.7± 21.1 o0.001
Insulin (μIU ml− 1) 12.2± 5.7 29.7± 10.7 o0.001
GIP (pgml− 1) 64.4± 10.0 109.2± 44.4 o0.001
GLP1 (pmol l− 1) 1.8± 0.5 7.6± 1.7 o0.001
DPP-4 concentration (pgml− 1) 373.8± 67.1 490.0± 49.3 o0.001
DPP-4 activity (μUml− 1) 26.8± 5.9 41.2± 6.9 o0.001
HDL-C (mg dl− 1) 75.3± 13.1 76.3± 19.1 NS
Triglycerides (mg dl− 1) 93.5± 6.7 115.7± 8.6 o0.001
LDL-C (mg dl− 1) 69.5± 17.4 87.4± 12.9 o0.001
ox-LDL (mUml− 1) 58.0± 14.6 114.8± 21.2 o0.001
Abbreviations: DPP-4, Dipeptidyl peptidase-4; EVOO, extra virgin olive oil; GIP, glucose-dependent insulinotropic polypeptide; GLP1, glucagon-like peptide-1;
HDL, high-density lipoprotein; NS, not significant; Ox-LDL, oxidized LDL; low-density lipoprotein; LDL-C, LDL-cholesterol; HDL-C, HDL-cholesterol.
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mechanism potentially accounting for the antiatherosclerotic
effect of the Mediterranean diet.
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